Daniele N. Debruyne - Publications

The role of the heart-on-a-chip to drug evaluation

Journal: Annales de biologie clinique

Published: July 02, 2026

National reflection on organs-on-chip for drug development: New regulatory challenges.

Journal: Toxicology letters

Published: July 19, 2023

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: February 27, 2023

Use of synthetic substances in France and in Europe

Journal: Therapie

Published: May 06, 2020

Warning on increased serious health complications related to non-medical use of nitrous oxide.

Journal: Therapie

Published: January 10, 2020

Title Not Found

Journal: Therapie

Published: January 10, 2020

Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study.

Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Published: November 11, 2018

DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.

Journal: Oncogene

Published: May 03, 2017

Focus on cannabinoids and synthetic cannabinoids.

Journal: Clinical pharmacology and therapeutics

Published: August 19, 2016

The current aspects of the use of ecstasy/MDMA in France

Journal: Therapie

Published: February 26, 2016

Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related Peritonitis.

Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Published: January 28, 2016

Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis.

Journal: Expert opinion on drug metabolism & toxicology

Published: December 25, 2015